UnitedHealth Group IncorporatedNYSE: UNH

CVS Health, UnitedHealth Group, and Cigna have filed a lawsuit against the Federal Trade Commission, arguing that the agency's case regarding high insulin prices in the U.S. is unconstitutional. This complaint adds to the ongoing legal battle between the three biggest pharmacy benefit managers (PBMs) in the country and the FTC.

In the most recent trading session, UnitedHealth Group (UNH) finished at $589.65, which is a decrease of 0.44% compared to the day before.

This Analyst Blog features UnitedHealth, Bank of America, and SAP SE.

UnitedHealth (UNH) shared its earnings report 30 days ago. What can we expect for the stock moving forward?

The DOJ believes that UNH's purchases show a plan to acquire its rivals instead of competing with them directly, which could allow it to dominate several markets.

On Tuesday, the Justice Department and three U.S. states announced they are suing to prevent UnitedHealth Group from buying Amedisys Inc for $3.3 billion. They are worried that this acquisition could negatively affect competition in the home health services market.

The healthcare industry is large and consists of both big, well-known companies like UnitedHealth Group Inc. and McKesson Corp., as well as smaller, newer pharmaceutical companies. Investors in this sector can choose to invest in established firms that have stable operations but may not grow as quickly, or they can opt for smaller companies that come with more risk but also the potential for greater rewards.

Users of Zacks.com have been paying a lot of attention to UnitedHealth (UNH) lately. Therefore, it's important to understand the key information that could influence the stock's future.

--(BUSINESS WIRE)--UnitedHealth Group has announced its quarterly dividend.